<DOC>
	<DOCNO>NCT02521818</DOCNO>
	<brief_summary>This trial seek establish feasibility implement ketogenic , modified Atkins diet ( MAD ) old adult mild cognitive impairment ( MCI ) early Alzheimer 's disease ( AD ) live community . A secondary aim determine whether adherence MAD result well cognitive test score adherence non-ketogenic control diet . A final aim determine role apolipoprotein E ( ApoE ) genotype participant ' response MAD . Participants randomly assign 12-week trial either MAD placebo diet base National Institute Aging 's recommendation senior nutrition .</brief_summary>
	<brief_title>Dietary Treatments Cognitive Impairment Older Adults</brief_title>
	<detailed_description>It well establish Alzheimer 's disease ( AD ) associate insulin resistance , hence , abnormal glucose metabolism . In fact , abnormalities brain 's uptake glucose observe PET image advance clinical symptom . In patient establish dementia due AD , severity cognitive impairment strongly correlate decrease glucose uptake . Ketone body , product fat metabolism , serve `` backup '' fuel glucose unavailable . Ketone body metabolism appear bypass metabolic process abnormal AD may provide good nourishment neuron . As result , ketone body metabolism may slow cognitive decline even improve cognition patient AD . Participants 50 people , age 65 old , MCI mild probable AD without significant cardiovascular disease . They require obtain consent primary care physicians participation . Each patient study partner cognitively healthy , live participant , help him/her adhere diet . A research dietitian teach participant partner new diet monitor participant ' adherence food log , in-person assessment , urine ketone testing . After initial baseline visit , participant complete four in-person assessment adherence diet assess neurocognitive test administer . It hypothesize MAD feasible well tolerated senior MCI AD . It hypothesize adherence MAD associate great increase ( less decline ) cognitive test score placebo diet , particularly participant carry ApoE Îµ4 allele .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>diagnosis mild cognitive impairment Alzheimer 's disease availability cohabitating study partner without cognitive impairment consent primary care physician history stroke history coronary artery disease history pancreatitis untreated hypothyroidism B12 deficiency history renal disease recurrent kidney stone history liver disease insulindependent diabetes body mass index &lt; 18.5 multiple food allergy follow strict diet ( e.g. , vegetarian , glutenfree )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cognition</keyword>
	<keyword>dementia</keyword>
	<keyword>neuropsychological</keyword>
	<keyword>elderly</keyword>
	<keyword>nutrition</keyword>
	<keyword>diet</keyword>
</DOC>